Protein Creatinine Ratio, Urine (UPCR)

Kidney

Report in 4Hrs

At Home

No Fasting Required

Details

Evaluates protein loss in urine normalized to creatinine; used in diagnosing and monitoring kidney disease.

₹249₹900

72% OFF

Protein Creatinine Ratio Urine (UPCR) - Comprehensive Medical Test Guide

Why is it done?
- Test Description: The UPCR measures the amount of protein in urine relative to creatinine levels, providing a standardized assessment of proteinuria independent of urine concentration and hydration status.
- Primary Indications:
  - Detection and monitoring of proteinuria in patients with diabetes mellitus
  - Assessment of kidney function in hypertensive patients
  - Evaluation of chronic kidney disease (CKD) severity and progression
  - Monitoring therapeutic response to medications targeting proteinuria
  - Investigation of abnormal urine dipstick findings
  - Assessment of glomerulonephritis and other primary kidney diseases
- Timing: Performed during routine physical examinations, in acute clinical settings when kidney disease is suspected, or at regular intervals for chronic disease monitoring.
Normal Range
- Reference Values:
  - Normal/Negative: <0.15 g/g creatinine (or <15 mg/g creatinine)
  - Microalbuminuria (early kidney disease): 0.03-0.30 g/g creatinine (or 30-300 mg/g creatinine)
  - Macroalbuminuria (significant proteinuria): >0.30 g/g creatinine (or >300 mg/g creatinine)
  - Nephrotic range: >3.0 g/g creatinine (or >3000 mg/g creatinine)
- Units of Measurement: g/g creatinine or mg/g creatinine (Some labs may report as mg/mmol creatinine)
- Result Interpretation:
  - Negative: Indicates normal kidney function with no significant protein loss; minimal kidney damage
  - Borderline/Microalbuminuria: Early indicator of kidney disease; may respond to intervention
  - Elevated/Macroalbuminuria: Suggests moderate to advanced kidney disease; requires treatment
  - Nephrotic Range: Indicates severe kidney disease with substantial protein loss; requires urgent medical attention
Interpretation
- Clinical Significance:
  - UPCR <0.15: Normal finding; no proteinuria detected; kidney filtration function intact
  - UPCR 0.03-0.30: Indicates microalbuminuria; typically first sign of diabetic kidney disease; strong predictor of progression to overt proteinuria
  - UPCR >0.30: Denotes macroalbuminuria; indicates significant glomerular damage; associated with accelerated decline in renal function
  - UPCR >3.0: Nephrotic-range proteinuria; indicates severe kidney damage; associated with hypoalbuminemia, edema, and hyperlipidemia
- Factors Affecting Results:
  - Acute infection or urinary tract infection (can cause temporary proteinuria)
  - Intense physical exercise or fever (may increase protein levels temporarily)
  - Menstrual cycle phase and pregnancy (hormonal influences on protein excretion)
  - Hematuria (presence of blood in urine can elevate protein measurements)
  - Medication side effects (NSAIDs, certain antibiotics, lithium)
  - Dehydration or excessive fluid intake (affects urine concentration)
- Result Patterns and Implications:
  - Progressive increase: Suggests worsening kidney function; requires intervention and possible medication adjustment
  - Stable elevated levels: Indicates chronic kidney disease with current disease process; ongoing monitoring essential
  - Decreasing levels: Suggests therapeutic effectiveness of treatment; beneficial response to medications
  - High variability: May indicate intermittent proteinuria; repeat testing recommended to confirm diagnosis
Associated Organs
- Primary Organ System: The kidneys and urinary system
  - Specifically measures glomerular filtration function and renal tubular integrity
- Conditions Associated with Abnormal Results:
  - Diabetic Nephropathy: Most common cause of CKD worldwide; progressive kidney damage in diabetes patients
  - Hypertensive Nephrosclerosis: Kidney damage secondary to chronic hypertension
  - IgA Nephropathy: Most common primary glomerulonephritis; immune complex deposition in kidneys
  - Lupus Nephritis: Kidney involvement in systemic lupus erythematosus; autoimmune glomerulonephritis
  - Focal Segmental Glomerulosclerosis (FSGS): Primary kidney disease characterized by glomerular scarring
  - Membranous Nephropathy: Autoimmune glomerulonephritis; a leading cause of nephrotic syndrome
  - Post-Infectious Glomerulonephritis: Kidney inflammation following streptococcal or other infections
  - Polycystic Kidney Disease: Genetic disorder leading to progressive kidney damage
  - Preeclampsia/Eclampsia: Pregnancy-related condition with renal involvement and proteinuria
  - Drug-Induced Nephropathy: Kidney damage from medications (NSAIDs, ACE inhibitors, lithium)
- Potential Complications of Abnormal Results:
  - Progressive chronic kidney disease leading to end-stage renal disease (ESRD)
  - Nephrotic syndrome with severe proteinuria, hypoalbuminemia, and edema
  - Cardiovascular complications including hypertension and atherosclerosis
  - Requirement for dialysis or kidney transplantation
  - Electrolyte imbalances and fluid retention complications
  - Anemia secondary to decreased erythropoietin production
  - Metabolic bone disease and mineral metabolism abnormalities
Follow-up Tests
- Recommended Additional Tests Based on Abnormal Results:
  - Serum Creatinine and eGFR: Assess overall kidney function and glomerular filtration rate
  - Blood Urea Nitrogen (BUN): Evaluate kidney's ability to filter waste products
  - Serum Albumin: Determine if significant protein loss has led to hypoalbuminemia
  - Lipid Panel: Assess for dyslipidemia often associated with nephrotic syndrome
  - Urinalysis: Evaluate for hematuria, cast formation, and other abnormalities
  - 24-Hour Urine Protein Collection: Quantify total daily protein excretion
  - Kidney Ultrasound or MRI: Visualize kidney structure and identify underlying pathology
  - Renal Biopsy: Definitive diagnosis for primary glomerulonephritis when diagnosis unclear
- Immunological Testing (if indicated):
  - ANA (Antinuclear Antibody) for suspected lupus nephritis
  - ANCA (Anti-Neutrophil Cytoplasmic Antibody) for vasculitis screening
  - Complement levels (C3, C4) for assessment of immune-mediated kidney disease
- Monitoring Frequency for Chronic Conditions:
  - Diabetes patients: Annually for early detection of microalbuminuria
  - Hypertensive patients with CKD: Every 3-6 months depending on disease stage
  - Advanced CKD (Stage 4-5): Every 1-3 months for close monitoring
  - Glomerulonephritis during treatment: Every 3-6 months to assess therapeutic response
- Related Complementary Tests:
  - Urine Albumin-to-Creatinine Ratio (ACR): Alternative method with similar clinical utility
  - Cystatin C: Alternative marker of glomerular filtration, less affected by muscle mass
  - Blood Pressure Monitoring: Critical assessment parallel to UPCR testing
Fasting Required?
- Fasting Requirement:
  - No - Fasting is not required for UPCR testing
- Patient Preparation Requirements:
  - Hydration: Maintain normal fluid intake; avoid excessive dehydration or over-hydration prior to testing
  - Physical Activity: Avoid strenuous exercise or intense physical exertion 24-48 hours before collection
  - Menstrual Cycle: Women should collect sample when not menstruating, if possible, to avoid contamination
  - Acute Illness: Defer testing if acute infection or fever is present, as these temporarily elevate protein levels
- Medications: Continue all regularly prescribed medications unless otherwise instructed by physician
  - Do NOT discontinue ACE inhibitors or ARBs (beneficial for proteinuria reduction)
  - Inform provider if taking NSAIDs, as these may temporarily increase protein excretion
  - Notify provider of any recent antibiotic use or medication changes
- Specimen Collection Instructions:
  - Clean-catch midstream urine sample or random spot urine collection (most common method)
  - For Women: Cleanse urethral area from front to back before collection
  - For Men: Cleanse urethral opening with sterile wipe
  - Collect midstream urine (discard first portion and last portion)
  - Use sterile container provided by laboratory
  - Label sample with name, date of birth, and collection time
  - Transport to laboratory promptly (within 1-2 hours or refrigerate if delays expected)
- Timing Considerations:
  - Early morning first void is preferred (most concentrated urine with reliable creatinine level)
  - Random daytime specimens are acceptable for routine screening
  - Consistency: If serial measurements planned, collect at same time of day for comparability

How our test process works!